Research Advances on the Stability of mRNA Vaccines
Viruses · 02.03.2023 · 15 (3) · 668
DOI: 10.3390/v15030668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 02.03.2023. Verfasst von Feiran Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Products Administration Key Laboratory for Quality Research and Evaluation of Biological Products, Institute of Biological Products,…. Hauptthemen laut MEDLINE: Excipients, Commerce. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Compared to other vaccines, the inherent properties of messenger RNA (mRNA) vaccines and their interaction with lipid nanoparticles make them considerably unstable throughout their life cycles, impacting their effectiveness and global accessibility. It is imperative to improve mRNA vaccine stability and investigate the factors influencing stability. Since mRNA structure, excipients, lipid nanoparticle (LNP) delivery systems, and manufacturing processes are the primary factors affecting mRNA vaccine stability, optimizing mRNA structure and screening excipients can effectively improve mRNA vaccine stability. Moreover, improving manufacturing processes could also prepare thermally stable mRNA vaccines with safety and efficacy. Here, we review the regulatory guidance associated with mRNA vaccine stability, summarize key factors affecting mRNA vaccine stability, and propose a possible research path to improve mRNA vaccine stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Medical Products Administration Key Laboratory for Quality Research and Evaluation of Biological Products, Institute of Biological Products, National Institutes for Food and Drug Control, Beijing 102600, China.
- National Health Commission Key Laboratory of Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 102600, China.
- Center for Reference Materials and Standardization, National Institutes for Food and Drug Control, Beijing 102600, China.
ORCID-Profile: Feiran Cheng
Förderung
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Cheng, F., Wang, Y., Bai, Y., Liang, Z., Mao, Q., Liu, D., Wu, X., & Xu, M. (2023). Research Advances on the Stability of mRNA Vaccines. Viruses, 15(3), 668. https://doi.org/10.3390/v15030668
Vancouver
Cheng F, Wang Y, Bai Y, Liang Z, Mao Q, Liu D, et al. Research Advances on the Stability of mRNA Vaccines. Viruses. 2023;15(3):668. doi:10.3390/v15030668
BibTeX
@article{Cheng2023,
author = {Cheng, Feiran and Wang, Yiping and Bai, Yu and Liang, Zhenglun and Mao, Qunying and Liu, Dong and Wu, Xing and Xu, Miao},
title = {Research Advances on the Stability of mRNA Vaccines},
journal = {Viruses},
year = {2023},
volume = {15},
number = {3},
pages = {668},
doi = {10.3390/v15030668}
}
EUVIMED